Related Experiment Video
Updated: Aug 27, 2025

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
[Basic core promoter and precore mutations of hepatitis B virus].
Alexandra Ducancelle1, Adeline Pivert1, Françoise Lunel-Fabiani1
1CHU d'Angers, laboratoire de virologie, 4, rue Larrey, 49033 Angers Cedex, France.
Hepatitis B virus (HBV) replication generates diverse viral strains, including precore (PC) and basal core promoter (BCP) mutants. The clinical significance of these HBV mutations in chronic liver disease remains unclear.
Area of Science:
- Virology
- Molecular Biology
- Hepatology
Context:
- Hepatitis B virus (HBV) replication is characterized by high mutation rates due to error-prone reverse transcription.
- This leads to a quasispecies distribution of HBV within infected individuals.
- Specific variants, such as precore (PC) and basal core promoter (BCP) mutants, emerge through selection processes.
Purpose:
- To investigate the impact of HBV precore (PC) and basal core promoter (BCP) mutations on chronic liver disease.
- To understand the mechanisms by which these mutations affect viral protein synthesis and potentially disease progression.
Summary:
- HBV replication's error-prone nature results in quasispecies, favoring emergence of PC and BCP mutants.
- The dominant PC variant (G1896A) creates a stop codon, halting precore protein translation and HBe-antigen synthesis.
- BCP variants (A1762T/G1764A) reduce HBeAg production at the transcriptional level.
Impact:
- The clinical impact of PC and BCP mutations on the course of chronic hepatitis B liver disease is not well established.
- Further research is needed to clarify the role of these HBV variants in disease pathogenesis and outcomes.
More Related Videos
11:14Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
The Eukaryotic Promoter Region
Mechanisms of Retrovirus-induced Cancers
Viral Mutations
Retroviruses
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...